A Baltimore jury ordered Johnson & Johnson and its subsidiaries to pay over $1.5 billion to a woman who claimed decades of exposure to asbestos in the company’s talc-based products caused her ...
The diversification king . Johnson & Johnson is one of the more diversified healthcare stocks on the market. The company's business spans pharmaceuticals and medical devices. With ...
J&J generates over $20 billion of free cash flow per year, which allows the company to reinvest in the business and return ...
Drug-making giant Johnson & Johnson will officially start marketing four of its medications on the Trump administration's TrumpRx website on Friday, CBS News exclusively learned.
Johnson & Johnson's Tom Aelbrecht, N-VA's Jan Jambon, Flemish Minister for Welfare and Culture Caroline Gennez, Deputy department head of the nursing department Siska Van den Bergh, ZAS president Els ...
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) and AbbVie (NYSE:ABBV) both posted Q1 2026 results that beat revenue expectations and prompted raised full-year guidance. JNJ leaned on a ...
A Baltimore jury ordered Johnson & Johnson and its subsidiaries to pay over $1.5 billion to a woman who claimed decades of exposure to asbestos in the company’s talc-based products caused her ...
On Sept. 29, 1982, Mary Kellerman woke up feeling sick. The 12-year-old girl from Elk Grove Village, a suburb of Chicago, asked her parents to stay home from school, and they gave her one ...
On a special episode (first released on May 21, 2025) of The Excerpt podcast: For generations of Americans, the Johnson & Johnson brand has been a beloved one, as quintessentially American as baseball ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results